DataStar, Dialog, and Ovid to Host EMBASE Classic Database from Elsevier
Electronic Backfile from 1947 – 1973
Amsterdam, August 22, 2007 – Elsevier, the leading publisher of scientific, technical and medical information and producer of EMBASE, announces that agreements have been signed with both Thomson Scientific and Wolters Kluwer Health to host the new EMBASE Classic bibliographic database on DataStar, Dialog, Ovid and SilverPlatter beginning fall 2007. This EMBASE Classic release will mark the first time that the EMBASE backfile from 1947-1973 will be accessible in electronic form. It will enable institutions to obtain perpetual access to this important body of information. To celebrate the upcoming release of EMBASE Classic, an introductory pre-launch sales offer is currently available.
"With EMBASE Classic, researchers will have access to the early literature on the market-leading Ovid platform that is so critical to understanding major developments in their field. This continues to fulfill the commitment of Wolters Kluwer Health to provide librarians with comprehensive information in important subject areas to support the research needs of their institution," said Scott MacFarland, Vice President of Content Management at Wolters Kluwer Health. "Our EMBASE implementation features industry-leading functionality of the EMTREE thesaurus, enabling researchers to quickly locate the precise information they need. EMBASE Classic will be an excellent addition and is the kind of offering our customers have come to expect from Ovid." EMBASE Classic will be available on both the Ovid Gateway and SilverPlatter WebSPIRS platforms.
"Thomson Scientific understands the vital need for archive data to enhance search and analysis capabilities, and the upcoming release of the EMBASE Classic database is sure to accelerate biomedical and pharmacological research efforts worldwide," said Geoffrey Dick, Director, Publisher Management, Thomson Scientific. "Combined with other archive data recently added to Dialog and DataStar, including BIOSIS and Zoological Record, EMBASE Classic will provide greater context for current and future research. We are pleased that we will soon be able to offer this valuable content to our Dialog and DataStar customers."
Amanda Spiteri, Director of Elsevier's Pharmaceutical Development Group, commented that, "Because this year marks the 60th anniversary of EMBASE, it makes it particularly gratifying to launch EMBASE Classic at this time, enabling today’s researchers to look back at critical research that has paved the way for advancements in science and medicine. We are very pleased to have reached agreements with two of the major online vendors."
EMBASE Classic is a fully digitized 27-year backfile that is drawn from 43 Excerpta Medica Abstract Journal print titles and includes more than 1.8 million bibliographic records of articles published in 3,000 international biomedical and pharmacological titles.
EMTREE, Elsevier's Life Science Thesaurus, has been implemented across the file for precision retrieval. The thesaurus contains over 52,000 preferred terms and more than 215,000 synonyms. Historic medical and drug terms have been identified and added to the current version of EMTREE. Please visit www.info.embaseclassic.com for a complete product overview.
Please contact your sales representative at Ovid, Dialog or DataStar today to find out how you can take advantage of the introductory sales offer.
EMBASE is a biomedical and pharmacological database that provides access to the most up-to-date information about medical and drug-related subjects. Updated weekly, it contains over 11 million records from 1974 to present, with 600,000+ citations and abstracts added annually. Each record contains the full bibliographic citation, indexing terms and codes; 70% of all citations in EMBASE include author-written abstracts. The EMBASE journal collection is international with over 5,000 biomedical journals from 70 countries. EMBASE features comprehensive coverage of Drug Research, Pharmacology, Pharmacy, Pharmacoeconomics, Pharmaceutics and Toxicology; Human Medicine (Clinical and Experimental); Basic Biological Research; Health Policy and Management; Public, Occupational and Environmental Health; Substance Dependence and Abuse; Psychiatry; Forensic Science; and Biomedical Engineering and Instrumentation.
About The Thomson Corporation
The Thomson Corporation is a global leader in providing essential electronic workflow solutions to business and professional customers. With operational headquarters in Stamford, Conn., Thomson provides value-added information, software tools and applications to professionals in the fields of law, tax, accounting, financial services, scientific research and healthcare. The Corporation’s common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).
Thomson Scientific is a business of The Thomson Corporation. Its information solutions assist professionals at every stage of research and development - from discovery to analysis to product development and distribution. Thomson Scientific information solutions can be found at scientific.thomson.com.
About Wolters Kluwer Health
Wolters Kluwer Health (Conshohocken, PA), a division of Wolters Kluwer, is a leading provider of information for professionals and students in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons; electronic information providers, such as Ovid Technologies, Medi-Span and ProVation; and pharmaceutical information providers Adis International and Source®. For more information, visit WKHealth.com.
Wolters Kluwer is a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal and regulatory sectors. Wolters Kluwer has 2006 annual revenues of €3.7 billion, employs approximately 19,900 people worldwide and maintains operations across Europe, North America, and Asia Pacific. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on the Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. For more information, visit WoltersKluwer.com.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
+31 20 485 3091